⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Pentadecanoic Acid (C15:0)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-11 — Pentadecanoic acid as a potential endogenous mTOR modulator for age-related female infertility: Mechanistic insights, molecular docking evidence, and therapeutic perspectives.: 2026-08 — Review + molecular docking paper proposes C15:0 as a pregnancy-compatible endogenous mTOR modulator for ovarian aging via AMPK activation and PPAR-α/δ modulation, with weaker mTOR kinase-domain binding than rapamycin; no human or animal fertility outcome data. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Pentadecanoic acid as a potential endogenous mTOR modulator for age-related female infertility: Mechanistic insights, molecular docking evidence, and therapeutic perspectives.
11-aug-2026
novelty 3
per-area 3
strengthens